PIA
VRTX icon

Piedmont Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Piedmont Investment Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-27,667
Closed -$6.58M – 679
2020
Q1 		$6.58M Buy
27,667
+3,696
+15% +$848K 0.26% 89
2019
Q4 		$5.25M Buy
23,971
+1,020
+4% +$206K 0.18% 129
2019
Q3 		$3.89M Buy
22,951
+329
+1% +$58.2K 0.15% 147
2019
Q2 		$4.15M Buy
22,622
+22
+0.1% +$3.85K 0.17% 139
2019
Q1 		$4.16M Buy
22,600
+349
+2% +$64.5K 0.17% 137
2018
Q4 		$3.69M Buy
22,251
+1,213
+6% +$210K 0.18% 125
2018
Q3 		$4.05M Buy
21,038
+10,061
+92% +$1.79M 0.17% 128
2018
Q2 		$1.87M Sell
10,977
-26,781
-71% -$4.15M 0.09% 227
2018
Q1 		$6.15M Sell
37,758
-16,347
-30% -$2.67M 0.16% 159
2017
Q4 		$8.11M Sell
54,105
-177
-0.3% -$26.2K 0.16% 165
2017
Q3 		$8.25M Buy
54,282
+1,151
+2% +$173K 0.18% 155
2017
Q2 		$6.85M Buy
53,131
+914
+2% +$110K 0.15% 176
2017
Q1 		$5.71M Buy
52,217
+454
+0.9% +$40K 0.12% 201
2016
Q4 		$3.81M Buy
51,763
+1,118
+2% +$91K 0.08% 227
2016
Q3 		$4.42M Sell
50,645
-5,233
-9% -$495K 0.1% 213
2016
Q2 		$4.81M Buy
55,878
+1,215
+2% +$105K 0.1% 205
2016
Q1 		$4.35M Buy
54,663
+840
+2% +$76K 0.09% 197
2015
Q4 		$6.77M Buy
53,823
+476
+0.9% +$57.5K 0.14% 155
2015
Q3 		$5.56M Buy
53,347
+427
+0.8% +$54.9K 0.13% 177
2015
Q2 		$6.53M Buy
+52,920
New +$6.67M 0.14% 172

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Piedmont Investment Advisors's VRTX Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Vertex Pharmaceuticals (VRTX) in Q2 2020, closing a stake of 27,667 shares — an estimated $6.58M sold.

Piedmont Investment Advisors first reported a position in VRTX in Q2 2015 and held it in 20 quarters. The position peaked at $8.25M in Q3 2017. 964 funds tracked by Wall St. Rank hold VRTX as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Vertex Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 27,667 Vertex Pharmaceuticals shares in Q2 2020, an estimated $6.58M.
  • Piedmont Investment Advisors first reported a position in Vertex Pharmaceuticals in Q2 2015 and held it in 20 quarters.
  • Piedmont Investment Advisors's Vertex Pharmaceuticals position peaked at $8.25M in Q3 2017.
  • 964 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.